[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Denada670519 DenadaDenada posts on X about $arwr, novartis, snapshot, blake the most. They currently have XXX followers and X posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXXX%
Social topic influence $arwr #6, novartis 11.11%, snapshot 11.11%, blake XXXXX%
Top accounts mentioned or mentioned by @wkissel @lsinnv
Top assets mentioned Arrowhead Research Corporation (ARWR) Novartis AG (NVS)
Top posts by engagements in the last XX hours
"New on Substack (Free): $ARWR How Arrowhead is funding its platform without dilution. A deep dive into their capital strategy using BD partnerships (Sarepta Novartis & others) not just to advance programs but to build runway. Capital generation (cash in) Capital conservation (risk & cost sharing) Not a deal recap a business-model analysis. #RNAI #Biotech"
X Link 2025-11-30T14:46Z XXX followers, 1975 engagements
"Big milestone for $ARWR today first patients dosed in the Phase 1/2a ARO-MAPT trial for Alzheimers & tauopathies. This is Arrowheads first clinical test of its systemic CNS RNAi delivery platform (subcutaneous dosing crossing the BBB). Safety/PK study in healthy volunteers + early AD patients; initial data expected 2H 2026. Platform moment now moving from preclinical proof into humans"
X Link 2025-12-08T12:37Z XXX followers, 1925 engagements
"Nice refresh from the Arrowhead communications team under new Director Jeff Blake. Clear snapshot of a company moving firmly into commercial execution mode. 2026 focus: REDEMPLO ramp SHTG Phase X in Q3 first DIMER-PA data in 2H plus steady progress across the obesity and CNS pipelines. $ARWR"
X Link 2025-12-10T12:39Z XXX followers, XXX engagements